BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2511710)

  • 1. [Specific intoxication in anthrax infection].
    Kolesnik VS; Tafel'shteĭn EE; Kolesnik RS; Sorkin IuI; Kalinovskiĭ AI
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Sep; (9):14-8. PubMed ID: 2511710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anthrax toxin dynamics in the body].
    Golubinskiĭ EP; Tafel'shteĭn EE; Kolesnik VS; Osipenko II; Kondrat'eva AM
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):98-100. PubMed ID: 2472713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacillus anthracis factors for phagosomal escape.
    Tonello F; Zornetta I
    Toxins (Basel); 2012 Jul; 4(7):536-53. PubMed ID: 22852067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental anthrax infection in laboratory animals with differing species susceptibility to the causative agent].
    Kolesnik VS; Kolesnik RS; Sorkin IuI; Kalinovskiĭ AI; Tafel'shteĭn EE; Starovoĭtova TP
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Jun; (6):3-7. PubMed ID: 2120875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early interactions between fully virulent Bacillus anthracis and macrophages that influence the balance between spore clearance and development of a lethal infection.
    Cote CK; DiMezzo TL; Banks DJ; France B; Bradley KA; Welkos SL
    Microbes Infect; 2008 May; 10(6):613-9. PubMed ID: 18467145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental characteristics of anthrax intoxication].
    Kolesnik VS; Tafel'shteĭn EE; Kolesnik RS; Starovoĭtova TP; Kondrat'eva AM
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):98-101. PubMed ID: 2446450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthrax Toxins in Context of Bacillus anthracis Spores and Spore Germination.
    Cote CK; Welkos SL
    Toxins (Basel); 2015 Aug; 7(8):3167-78. PubMed ID: 26287244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacillus anthracis spore movement does not require a carrier cell and is not affected by lethal toxin in human lung models.
    Booth JL; Duggan ES; Patel VI; Langer M; Wu W; Braun A; Coggeshall KM; Metcalf JP
    Microbes Infect; 2016 Oct; 18(10):615-626. PubMed ID: 27320392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthrax: from antiquity to answers.
    Artenstein AW
    J Infect Dis; 2007 Feb; 195(4):471-3. PubMed ID: 17230405
    [No Abstract]   [Full Text] [Related]  

  • 10. A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis.
    Majumder S; Das S; Somani V; Makam SS; Joseph KJ; Bhatnagar R
    Sci Rep; 2018 May; 8(1):7242. PubMed ID: 29740033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacillus anthracis genomic DNA enhances lethal toxin-induced cytotoxicity through TNF-α production.
    Jeon JH; Kim YH; Choi MK; Kim KA; Lee HR; Jang J; Kim YR; Chun JH; Eo SK; Kim TS; Rhie GE
    BMC Microbiol; 2014 Dec; 14():300. PubMed ID: 25472474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthrax toxins and the host: a story of intimacy.
    Mock M; Mignot T
    Cell Microbiol; 2003 Jan; 5(1):15-23. PubMed ID: 12542467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New aspects of the infection mechanisms of Bacillus anthracis.
    Zakowska D; Bartoszcze M; Niemcewicz M; Bielawska-Drózd A; Kocik J
    Ann Agric Environ Med; 2012; 19(4):613-8. PubMed ID: 23311776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Where and how do anthrax toxins exit endosomes to intoxicate host cells?
    Puhar A; Montecucco C
    Trends Microbiol; 2007 Nov; 15(11):477-82. PubMed ID: 17983750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.
    Peterson JW; Comer JE; Baze WB; Noffsinger DM; Wenglikowski A; Walberg KG; Hardcastle J; Pawlik J; Bush K; Taormina J; Moen S; Thomas J; Chatuev BM; Sower L; Chopra AK; Stanberry LR; Sawada R; Scholz WW; Sircar J
    Infect Immun; 2007 Jul; 75(7):3414-24. PubMed ID: 17452469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key aspects of the molecular and cellular basis of inhalational anthrax.
    Cote CK; Welkos SL; Bozue J
    Microbes Infect; 2011 Dec; 13(14-15):1146-55. PubMed ID: 21816231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo.
    Little SF; Webster WM; Fisher DE
    FEMS Immunol Med Microbiol; 2011 Jun; 62(1):11-22. PubMed ID: 21231965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax.
    Heninger S; Drysdale M; Lovchik J; Hutt J; Lipscomb MF; Koehler TM; Lyons CR
    Infect Immun; 2006 Nov; 74(11):6067-74. PubMed ID: 16923785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ratio of lethal and edema factors in rabbit systemic anthrax.
    Molin FD; Fasanella A; Simonato M; Garofolo G; Montecucco C; Tonello F
    Toxicon; 2008 Dec; 52(7):824-8. PubMed ID: 18812184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the biological effects of anthrax toxins: linking cellular to organismal responses.
    Guichard A; Nizet V; Bier E
    Microbes Infect; 2012 Feb; 14(2):97-118. PubMed ID: 21930233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.